NEED ASSISTANCE? | CALL 202-877-3627

Tag: FDA Grand Rounds

FDA Grand Rounds

FDA Grand Rounds: Gaining Insight into the Patient’s Experience by Harnessing the Power of Social Listening and FDA Archival Data—May 9, 2019

This presentation explores how to consistently and comprehensively capture the patient’s voice by using multiple Read More »

... Read More »
FDA Grand Rounds

FDA Grand Rounds: Bisphenol A: Toxicology and Pharmacokinetic Data to Inform On-Going Safety Assessments—Sept. 13, 2018

Bisphenol A (BPA) is a high-production-volume industrial chemical used in producing polycarbonate plastics and epoxy Read More »

... Read More »
FDA Grand Rounds

FDA Grand Rounds: FDA’s Predictive Toxicology Roadmap: Implications and Opportunities for Stakeholders—May 10, 2018

Toxicology is critical to FDA’s mission because it is applied across the breadth of FDA-regulated Read More »

... Read More »
FDA Grand Rounds

FDA Grand Rounds: Ethnicity- and Gender-related Differences in Alzheimer’s Disease—January 11, 2018

Minorities and women are particularly vulnerable to Alzheimer’s disease (AD). Women have a higher incidence Read More »

... Read More »
FDA Grand Rounds

FDA Grand Rounds: Assessing the Safety and Effectiveness of New and Emerging Therapeutic Ultrasound Technologies—Nov. 9, 2017

Ultrasound’s long history as a medical tool dates back to the 1940s.  Today, diagnostic ultrasound’s Read More »

... Read More »
FDA Grand Rounds

FDA Grand Rounds: Developing a Mechanistic Model-Based Approach to Assess Cardiac Safety of New Drugs—Sept. 14, 2017

“Developing a Mechanistic Model-Based Approach to Assess Cardiac Safety of New Drugs” will address the Read More »

... Read More »
FDA Grand Rounds

FDA Grand Rounds: GenomeTrakr: How a Large Network of Sequencing Laboratories is Transforming Food Safety and Public Health—July 13, 2017

“GenomeTrakr: How a Large Network of Sequencing Laboratories is Transforming Food Safety and Public Health” will Read More »

... Read More »